UCB SA (UCBJY)
64.25
-0.78
(-1.20%)
USD |
OTCM |
May 09, 16:00
UCB Price to Book Value: 2.458 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 2.458 |
May 08, 2024 | 2.488 |
May 07, 2024 | 2.465 |
May 06, 2024 | 2.467 |
May 03, 2024 | 2.482 |
May 02, 2024 | 2.509 |
May 01, 2024 | 2.550 |
April 30, 2024 | 2.534 |
April 29, 2024 | 2.527 |
April 26, 2024 | 2.543 |
April 25, 2024 | 2.575 |
April 24, 2024 | 2.479 |
April 23, 2024 | 2.497 |
April 22, 2024 | 2.484 |
April 19, 2024 | 2.469 |
April 18, 2024 | 2.436 |
April 17, 2024 | 2.451 |
April 16, 2024 | 2.422 |
April 15, 2024 | 2.410 |
April 12, 2024 | 2.444 |
April 11, 2024 | 2.412 |
April 10, 2024 | 2.370 |
April 09, 2024 | 2.364 |
April 08, 2024 | 2.377 |
April 05, 2024 | 2.365 |
Date | Value |
---|---|
April 04, 2024 | 2.382 |
April 03, 2024 | 2.378 |
April 02, 2024 | 2.360 |
April 01, 2024 | 2.350 |
March 28, 2024 | 2.357 |
March 27, 2024 | 2.356 |
March 26, 2024 | 2.367 |
March 25, 2024 | 2.389 |
March 22, 2024 | 2.363 |
March 21, 2024 | 2.314 |
March 20, 2024 | 2.250 |
March 19, 2024 | 2.245 |
March 18, 2024 | 2.227 |
March 15, 2024 | 2.181 |
March 14, 2024 | 2.220 |
March 13, 2024 | 2.240 |
March 12, 2024 | 2.262 |
March 11, 2024 | 2.273 |
March 08, 2024 | 2.296 |
March 07, 2024 | 2.297 |
March 06, 2024 | 2.273 |
March 05, 2024 | 2.208 |
March 04, 2024 | 2.244 |
March 01, 2024 | 2.255 |
February 29, 2024 | 2.202 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.347
Minimum
Sep 22 2022
3.224
Maximum
Jul 30 2020
2.041
Average
2.025
Median
Mar 09 2021
Price to Book Value Benchmarks
Galapagos NV | 0.6064 |
Mithra Pharmaceuticals SA | -- |
Nyxoah SA | 2.255 |
Celyad Oncology SA | -- |
MDxHealth SA | -- |
Price to Book Value Related Metrics
PE Ratio | 67.03 |
PS Ratio | 4.407 |
Price to Free Cash Flow | 52.20 |
Price | 64.25 |
Earnings Yield | 1.49% |
Market Cap | 24.39B |
Operating PE Ratio | 36.44 |
Normalized PE Ratio | 67.34 |